Study of induction chemotherapy efficacy in oral squamous cell carcinoma using pseudotargeted metabolomics

Journal of Proteome Research

Volumn 13, Issue 4, 2014, Pages 1994-2004

  Ye, Guozhu ^a   Liu, Ying ^b   Yin, Peiyuan ^a   Zeng, Zhongda ^a   Huang, Qiang ^a   Kong, Hongwei ^a   Lu, Xin ^a   Zhong, Laiping ^b   Zhang, Zhiyuan ^b   Xu, Guowang ^a  

^a DALIAN INSTITUTE OF CHEMICAL PHYSICS   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

induction chemotherapy; metabolomics; oral squamous cell carcinoma; personalized medicine; potential biomarkers; pseudotargeted metabolomics

Indexed keywords

ALANINE; ALPHA TOCOPHEROL; ANTIBIOTIC AGENT; ANTIEMETIC AGENT; ASPARTIC ACID; BIOLOGICAL MARKER; CHOLESTEROL; CISPLATIN; DEXAMETHASONE; DIURETIC AGENT; DOCETAXEL; ETHANOLAMINE; FLUOROURACIL; GAMMA TOCOPHEROL; GLUCOSE; GLUTAMIC ACID; GLYCEROL; GLYCINE; ISOLEUCINE; LACTIC ACID; LANOSTEROL; LEUCINE; PYROGLUTAMIC ACID; SITOSTEROL; ANTINEOPLASTIC AGENT; TUMOR MARKER;

ACCURACY; ADULT; AGED; AMINO ACID METABOLISM; ARTICLE; BLOOD ANALYSIS; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CLINICAL ARTICLE; CONTINUOUS INFUSION; DRUG EFFICACY; DRUG RESPONSE; FEMALE; GLYCOLYSIS; HUMAN; HUMAN TISSUE; INDUCTION CHEMOTHERAPY; MALE; METABOLOME; METABOLOMICS; MOUTH SQUAMOUS CELL CARCINOMA; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; CARCINOMA, SQUAMOUS CELL; DRUG EFFECTS; METABOLISM; MIDDLE AGED; MOUTH NEOPLASMS; PERSONALIZED MEDICINE; PROCEDURES;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; INDIVIDUALIZED MEDICINE; INDUCTION CHEMOTHERAPY; MALE; METABOLOME; METABOLOMICS; MIDDLE AGED; MOUTH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84898746236     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr4011298     Document Type: Article

References (32)

1. Neville, B. W.; Day, T. A. Oral cancer and precancerous lesions Ca-Cancer J. Clin. 2002, 52 (4) 195-215
2. Parkin, D. M.; Bray, F.; Ferlay, J.; Pisani, P. Global cancer statistics, 2002 Ca-Cancer J. Clin. 2005, 55 (2) 74-108
3. Pignon, J.-P.; le Maitre, A.; Maillard, E.; Bourhis, J.; Grp, M.-N. C. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients Radiother. Oncol. 2009, 92 (1) 4-14
4. Zhong, L. P.; Zhang, C. P.; Ren, G. X.; Guo, W.; William, W. N., Jr.; Sun, J.; Zhu, H. G.; Tu, W. Y.; Li, J.; Cai, Y. L.; Wang, L. Z.; Fan, X. D.; Wang, Z. H.; Hu, Y. J.; Ji, T.; Yang, W. J.; Ye, W. M.; He, Y.; Wang, Y. A.; Xu, L. Q.; Wang, B. S.; Kies, M. S.; Lee, J. J.; Myers, J. N.; Zhang, Z. Y. Randomized phase III trial of induction chemotherapy with docetaxel, cisplatin, and fluorouracil followed by surgery versus up-front surgery in locally advanced resectable oral squamous cell carcinoma J. Clin. Oncol. 2013, 31 (6) 744-751
5. Pignon, J.; Bourhis, J.; Domenge, C.; Designe, L. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data Lancet 2000, 355 (9208) 949-955
6. Tan, Y.; Yin, P.; Tang, L.; Xing, W.; Huang, Q.; Cao, D.; Zhao, X.; Wang, W.; Lu, X.; Xu, Z.; Wang, H.; Xu, G. Metabolomics study of stepwise hepatocarcinogenesis from the model rats to patients: potential biomarkers effective for small hepatocellular carcinoma diagnosis Mol. Cell. Proteomics 2012, 11 (2) M111.010694
7. Chen, J.; Zhang, X.; Cao, R.; Lu, X.; Zhao, S.; Fekete, A.; Huang, Q.; Schmitt-Kopplin, P.; Wang, Y.; Xu, Z.; Wan, X.; Wu, X.; Zhao, N.; Xu, C.; Xu, G. Serum 27-nor-5beta-cholestane-3,7,12,24,25 pentol glucuronide discovered by metabolomics as potential diagnostic biomarker for epithelium ovarian cancer J. Proteome Res. 2011, 10 (5) 2625-2632
8. Wei, S.; Liu, L.; Zhang, J.; Bowers, J.; Gowda, G. A.; Seeger, H.; Fehm, T.; Neubauer, H. J.; Vogel, U.; Clare, S. E.; Raftery, D. Metabolomics approach for predicting response to neoadjuvant chemotherapy for breast cancer Mol. Oncol. 2013, 7 (3) 297-307
9. Roodhart, J. M. L.; Daenen, L. G. M.; Stigter, E. C. A.; Prins, H.-J.; Gerrits, J.; Houthuijzen, J. M.; Gerritsen, M. G.; Schipper, H. S.; Backer, M. J. G.; van Amersfoort, M.; Vermaat, J. S. P.; Moerer, P.; Ishihara, K.; Kalkhoven, E.; Beijnen, J. H.; Derksen, P. W. B.; Medema, R. H.; Martens, A. C.; Brenkman, A. B.; Voest, E. E. Mesenchymal Stem Cells Induce Resistance to Chemotherapy through the Release of Platinum-Induced Fatty Acids Cancer Cell 2011, 20 (3) 370-383
10. Weaver, Z.; Difilippantonio, S.; Carretero, J.; Martin, P. L.; El Meskini, R.; Iacovelli, A. J.; Gumprecht, M.; Kulaga, A.; Guerin, T.; Schlomer, J.; Baran, M.; Kozlov, S.; McCann, T.; Mena, S.; Al-Shahrour, F.; Alexander, D.; Wong, K. K.; Van Dyke, T. Temporal Molecular and Biological Assessment of an Erlotinib-Resistant Lung Adenocarcinoma Model Reveals Markers of Tumor Progression and Treatment Response Cancer Res. 2012, 72 (22) 5921-5933
11. Backshall, A.; Sharma, R.; Clarke, S. J.; Keun, H. C. Pharmacometabonomic profiling as a predictor of toxicity in patients with inoperable colorectal cancer treated with capecitabine Clin. Cancer Res. 2011, 17 (9) 3019-3028
12. Ye, G.; Zhu, B.; Yao, Z.; Yin, P.; Lu, X.; Kong, H.; Fan, F.; Jiao, B.; Xu, G. Analysis of urinary metabolic signatures of early hepatocellular carcinoma recurrence after surgical removal using gas chromatography-mass spectrometry J Proteome Res 2012, 11 (8) 4361-4372
13. Li, Y.; Ruan, Q.; Li, Y.; Ye, G.; Lu, X.; Lin, X.; Xu, G. A novel approach to transforming a non-targeted metabolic profiling method to a pseudo-targeted method using the retention time locking gas chromatography/mass spectrometry-selected ions monitoring J. Chromatogr., A 2012, 1255, 228-236
14. Chen, S.; Kong, H.; Lu, X.; Li, Y.; Yin, P.; Zeng, Z.; Xu, G. Pseudotargeted Metabolomics method and its application in serum biomarker discovery for hepatocellular carcinoma based on ultra gigh-performance liquid chromatography/triple quadrupole mass spectrometry Anal. Chem. 2013, 85 (17) 8326-8333
15. Licitra, L.; Grandi, C.; Guzzo, M.; Mariani, L.; Lo Vullo, S.; Valvo, F.; Quattrone, P.; Valagussa, P.; Bonadonna, G.; Molinari, R.; Cantu, G. Primary chemotherapy in resectable oral cavity squamous cell cancer: A randomized controlled trial J. Clin. Oncol. 2003, 21 (2) 327-333
16. Saeed, A. I.; Bhagabati, N. K.; Braisted, J. C.; Liang, W.; Sharov, V.; Howe, E. A.; Li, J.; Thiagarajan, M.; White, J. A.; Quackenbush, J. TM4 microarray software suite Methods Enzymol. 2006, 411, 134-193
17. Xia, J.; Mandal, R.; Sinelnikov, I. V.; Broadhurst, D.; Wishart, D. S. MetaboAnalyst 2.0 - a comprehensive server for metabolomic data analysis Nucleic Acids Res. 2012, 40 (W1) W127-W133
18. Chong, I.-G.; Jun, C.-H. Performance of some variable selection methods when multicollinearity is present Chemom. Intell. Lab. Syst. 2005, 78 (1) 103-112
19. Wold, S.; Sjöström, M.; Eriksson, L. PLS-regression: a basic tool of chemometrics Chemom. Intell. Lab. Syst. 2001, 58 (2) 109-130
20. Breiman, L. Random forests Mach. Learn. 2001, 45 (1) 5-32
21. Ronchetti, E.; Field, C.; Blanchard, W. Robust linear model selection by cross-validation J. Am. Stat. Assoc. 1997, 92 (439) 1017-1023
22. Shao, J. Linear model selection by cross-validation J. Am. Stat. Assoc. 1993, 88 (422) 486-494
23. Xu, Q.-S.; Liang, Y.-Z. Monte Carlo cross validation Chemom. Intell. Lab. Syst. 2001, 56 (1) 1-11
24. Gika, H. G.; Theodoridis, G. A.; Wingate, J. E.; Wilson, I. D. Within-day reproducibility of an HPLC-MS-Based method for metabonomic analysis: application to human urine J. Proteome Res. 2007, 6 (8) 3291-3303
25. Begley, P.; Francis-McIntyre, S.; Dunn, W. B.; Broadhurst, D. I.; Halsall, A.; Tseng, A.; Knowles, J.; Goodacre, R.; Kell, D. B. Consortium, H., Development and Performance of a Gas Chromatography-Time-of-Flight Mass Spectrometry Analysis for Large-Scale Nontargeted Metabolomic Studies of Human Serum Anal. Chem. 2009, 81 (16) 7038-7046
26. Guidance for Industry: Bioanalytical Method Validation; U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Veterinary Medicine (CVM), May 2001. http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/ guidances/ucm070107.pdf.
27. Keun, H. C.; Sidhu, J.; Pchejetski, D.; Lewis, J. S.; Marconell, H.; Patterson, M.; Bloom, S. R.; Amber, V.; Coombes, R. C.; Stebbing, J. Serum Molecular Signatures of Weight Change during Early Breast Cancer Chemotherapy Clin. Cancer Res. 2009, 15 (21) 6716-6723
28. Wang, J.; Alexander, P.; Wu, L.; Hammer, R.; Cleaver, O.; McKnight, S. L. Dependence of mouse embryonic stem cells on threonine catabolism Science 2009, 325 (5939) 435-439
29. Shyh-Chang, N.; Locasale, J. W.; Lyssiotis, C. A.; Zheng, Y.; Teo, R. Y.; Ratanasirintrawoot, S.; Zhang, J.; Onder, T.; Unternaehrer, J. J.; Zhu, H.; Asara, J. M.; Daley, G. Q.; Cantley, L. C. Influence of Threonine Metabolism on S-Adenosylmethionine and Histone Methylation Science 2013, 339 (6116) 222-226
30. Balendiran, G. K.; Dabur, R.; Fraser, D. The role of glutathione in cancer Cell Biochem. Funct. 2004, 22 (6) 343-352
31. Kaddurah-Daouk, R.; Weinshilboum, R. M. Pharmacometabolomics: implications for clinical pharmacology and systems pharmacology Clin. Pharmacol. Ther. 2014, 95 (2) 154-167
32. Clayton, T. A.; Lindon, J. C.; Cloarec, O.; Antti, H.; Charuel, C.; Hanton, G.; Provost, J. P.; Le Net, J. L.; Baker, D.; Walley, R. J.; Everett, J. R.; Nicholson, J. K. Pharmaco-metabonomic phenotyping and personalized drug treatment Nature 2006, 440 (7087) 1073-1077